Romero-PinelLPujalJMMartínez-YélamosS. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. Eur J Neurol2011; 18: 337–342.
2.
GhabaeeMBayatiAAmri SaroukolaeiS. Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cell Mol Neurobiol2009; 29: 109–114.
3.
WeinshenkerBGSantrachPBissonetAS. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology1998; 51: 742–747.
4.
ZivadinovRUxaLBratinaA. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Int Rev Neurobiol2007; 79: 521–535.
5.
WasayMAliSKhatriIA. Multiple sclerosis in Pakistan. Mult Scler2007; 13: 668–669.
6.
MoatterTAbanMTabassumSShaikhUPervezS. Molecular analysis of human leukocyte antigen class I and class II allele frequencies and haplotype distribution in Pakistani population. Indian J Hum Genet2010; 16: 149–153.
